• Learning Objective 1: Attendees will know the most significant known SARS-COV2 variants.
  • Learning Objective 2: Attendees will understand how genetic mutations in SARS-COV2 change infectiousness and resistance to vaccines or therapies.
  • Learning Objective 3: Attendees will understand public health implications of SARS-COV2 variants and how their spread and impact may be mitigated.
Session date: 
Tuesday, February 16, 2021 - 5:00pm to 6:00pm
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr's Daniel B. Ash & Pooja Gala